- Home
- FONR vs RPTX Comparison
FONR vs RPTX Comparison
Compare FONR & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FONR | RPTX |
|---|---|---|
| Founded | 1978 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.3M | 92.4M |
| IPO Year | 1987 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FONR | RPTX |
|---|---|---|
| Price | $14.59 | $2.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 32.0K | ★ 1.2M |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $105,434,318.00 | $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.55 |
| P/E Ratio | $13.27 | ★ N/A |
| Revenue Growth | ★ 3.36 | N/A |
| 52 Week Low | $12.00 | $0.89 |
| 52 Week High | $17.62 | $4.07 |
Technical Indicators
Market Signals| Indicator | FONR | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 62.37 |
| Support Level | $14.07 | $2.11 |
| Resistance Level | $14.60 | $2.17 |
| Average True Range (ATR) | 0.32 | 0.08 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 52.31 | 78.46 |
Price Performance
Historical ComparisonAbout FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.